Illumina Inc (ILMN)

Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 PR Newswire SAN DIEGO, July 9, 2026 SAN DIEGO, July...

Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer

Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer PR Newswire SAN DIEGO, July 9, 2026 New...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors

Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors PR Newswire SAN DIEGO, June 23...

Form 4 - Statement of changes in beneficial ownership of securities

Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution

Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities